My primary research area is in leukaemia (focussing specifically on chronic lymphocytic leukaemia). My Research Group includes post-doctoral and doctoral researchers as well as undergraduate students, and focusses on techniques to quantify changes functional behaviour related to drug effect focussing on novel signal-inhibitor drugs, incorporating proteomic and nanoparticle approaches with collaborators within Manchester.